GlassScriptPhysician profile
Hemchand Kolli
NPI 1669552485
$19,710.48
in general payments reported to CMS, 2019-2025
75 companies · $2,549 in 2025
The $2,549 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,283 · 2020: $2,923 · 2021: $2,688 · 2022: $4,424 · 2023: $2,534 · 2024: $2,309 · 2025: $2,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,392.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,950.16 | 2022 | |
| Abbvie INC. | $1,601.26 | 2019-2025 | |
| Amgen INC. | $1,385.95 | 2019-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,361.95 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,345.86 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $1,169.47 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $856.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $772.91 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $685.05 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Allergan, INC. | $677.07 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $619.20 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $594.05 | 2019-2024 | Tradjenta, Jardiance, Spiriva Respimat |
| Pfizer INC. | $493.56 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $472.69 | 2022-2025 | Rexulti, Abilify Asimtufii, Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $374.40 | 2021-2025 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $289.15 | 2020-2025 | Freestyle Libre 3 |
| Eisai INC. | $280.71 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $262.41 | 2019-2024 | |
| Dexcom, INC. | $239.78 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $227.19 | 2019-2023 | |
| Lundbeck LLC | $226.50 | 2020-2024 | Rexulti |
| Scilex Pharmaceuticals INC. | $203.82 | 2019-2023 | Ztlido |
| Esperion Therapeutics, INC. | $201.28 | 2020-2025 | Nexletol |
| Sunovion Pharmaceuticals INC. | $193.98 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $187.84 | 2021 | |
| Astellas Pharma US INC | $186.15 | 2019-2025 | Veozah, Myrbetriq |
| Corcept Therapeutics | $177.54 | 2020-2025 | Korlym |
| Janssen Biotech, INC. | $149.62 | 2025 | Tremfya |
| Radius Health, INC. | $134.84 | 2020-2024 | |
| Lexicon Pharmaceuticals, INC. | $131.81 | 2023-2024 | Inpefa |
| Amneal Pharmaceuticals LLC | $125.01 | 2023-2025 | Crexont, Rytary |
| Nestle Healthcare Nutrition INC. | $111.24 | 2021 | |
| Neurocrine Biosciences, INC. | $101.47 | 2024-2025 | Ingrezza |
| Phathom Pharmaceuticals, INC. | $99.22 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $99.19 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $94.17 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $91.67 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Shield Therapeutics INC | $90.14 | 2024-2025 | |
| Cvrx, INC. | $88.87 | 2022 | |
| Edwards Lifesciences Corporation | $86.53 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Ardelyx, INC. | $86.31 | 2024-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $82.91 | 2021-2024 | |
| Mannkind Corporation | $72.56 | 2019-2023 | Afrezza |
| Medtronic, INC. | $68.82 | 2022-2023 | Inpen Smart Insulin Delivery System |
| Gilead Sciences, INC. | $62.23 | 2019-2021 | |
| Insulet Corporation | $58.42 | 2025 | Omnipod |
| Arbor Pharmaceuticals, INC. | $56.43 | 2019-2022 | |
| Mdd US Operations, LLC | $55.34 | 2024 | Gocovri |
| Sumitomo Pharma America, INC. | $54.40 | 2024-2025 | Gemtesa |
| Paratek Pharmaceuticals, INC. | $53.33 | 2024-2025 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $50.16 | 2019-2020 | |
| Viiv Healthcare Company | $47.40 | 2019-2023 | Dovato |
| Grifols USA, LLC | $44.64 | 2019 | |
| Alnylam Pharmaceuticals INC. | $38.12 | 2020-2022 | |
| Biogen, INC. | $37.85 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.42 | 2024-2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $29.35 | 2023 | Quviviq |
| Avanir Pharmaceuticals, INC. | $24.69 | 2019 | |
| Medtronic Minimed, INC. | $24.36 | 2019-2020 | |
| Verona Pharma, INC. | $24.24 | 2025 | Ohtuvayre |
| Corium, LLC | $24.01 | 2023 | Adlarity |
| Circassia INC. | $23.12 | 2019-2020 | |
| Kyowa Kirin, INC. | $22.92 | 2024 | |
| Biocryst US Sales Co., LLC | $21.23 | 2023 | Orladeyo |
| Viatris Specialty LLC | $20.22 | 2025 | Yupelri |
| Daiichi Sankyo INC. | $19.01 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.58 | 2022 | |
| Cequr Corporation | $18.33 | 2023 | Cequr Simplicity |
| Ascend Therapeutics US, LLC | $16.00 | 2021 | |
| Metacel Pharmaceuticals LLC | $15.29 | 2023 | Ozobax |
| Smith+Nephew, INC. | $14.63 | 2019 | |
| Tactile Systems Technology INC | $14.44 | 2019 | |
| Evoke Pharma, INC. | $14.13 | 2025 | |
| Sanofi Pasteur INC. | $12.77 | 2020 | |
| Nevro Corp. | $12.03 | 2021 |
Drugs and devices associated with these payments
Rexulti $582Verquvo $574Otezla $529Repatha $504Trelegy Ellipta $411Breztri $373Rybelsus $330Ozempic $330Airsupra $330Farxiga $330Arexvy $255Xifaxan $249Jardiance $245Freestyle Libre 3 $202Xarelto $202Ubrelvy $176Dexcom G6 Transmitter $173Qulipta $170Mounjaro $164Vraylar $155Tremfya $150Wegovy $139Shingrix $129Zepbound $125Linzess $124Kerendia $118Evenity $111Ingrezza $101Voquezna $99.22Cologuard Collection Kit $99.19Nexletol $99.06Belsomra $97.84Accrufer $90.14Tradjenta $86.64Ibsrela $86.31Prolia $82.60Crexont $82.57Zavzpret $77.20Inpefa $74.62Leqvio $61.94Comirnaty $60.55Abrysvo $60.55Prevnar 20 $60.55Veozah $59.43Omnipod $58.42Gocovri $55.34Gemtesa $54.40Nuzyra $53.33Creon $43.28Spiriva Respimat $42.52Rytary $42.44Steglatro $41.69Ztlido $41.21Nurtec Odt $37.44Entresto $32.94Caplyta $32.42Korlym $31.41Avycaz $30.49Quviviq $29.35Edwards Sapien 3 Ultra Transcatheter Heart Valve $28.47Tavneos $28.47Capvaxive $26.13Enbrel $25.75Dovato $24.67Recorlev $24.51Ohtuvayre $24.24Adlarity $24.01Viberzi $23.31Afrezza $22.26Orladeyo $21.23Toujeo $20.49Yupelri $20.22Nucala $20.21Sapien 3 Ultra Resilia $20.11Abilify Asimtufii $19.89Eliquis $19.64Gvoke Hypopen $19.02Cequr Simplicity $18.33Soliqua 100/33 $16.63Jynarque $16.24Myrbetriq $16.21Stiolto Respimat $15.98Emgality $15.94Inpen Smart Insulin Delivery System $15.41Ozobax $15.29Gimoti $14.13Dalvance $4.14
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemchand Kolli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.